Switching between anti-TNFalpha agents: what is the evidence?
- PMID: 15182784
- DOI: 10.1016/j.jbspin.2003.10.009
Switching between anti-TNFalpha agents: what is the evidence?
Comment in
-
Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients.Joint Bone Spine. 2004 Nov;71(6):601-3. doi: 10.1016/j.jbspin.2004.07.009. Joint Bone Spine. 2004. PMID: 15589452 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
